Experiences with the use of oxaliplatin in esophageal carcinoma

Acta Oncol. 2006;45(1):103-5. doi: 10.1080/02841860500372319.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Chemotherapy, Adjuvant
  • Disease Progression
  • Esophageal Neoplasms / drug therapy*
  • Esophageal Neoplasms / mortality
  • Esophageal Neoplasms / surgery
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organoplatinum Compounds / adverse effects
  • Organoplatinum Compounds / therapeutic use*
  • Oxaliplatin
  • Survival Analysis
  • Treatment Outcome*

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin